EN
HI
Zim Laboratories share price chart
Zim Laboratories Share Key Metrics
Volume
78572.00
Market Cap
616.62 CR
LTQ@LTP
1@115.15
ATP
117.52
Var Margin
100 %
Circuit Range
108.74-120.18
Delivery %
0 %
Value
92.34 L
ASM/GSM
No
Market Lot
1
Summary
ZIMLAB stock price is ₹115.15 as of 7 Aug, 2026. The stock intraday movement has stayed between ₹112.00 and ₹120.18, while Zim Laboratories share price 52 week high low is ₹59.31 & ₹133.90.
In terms of trading activity, ZIMLAB share price has recorded a volume of 78,572 shares. The Zim Laboratories has a market cap of ₹53549037. The stock’s Average Traded Price (ATP) stands at ₹117.52, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹115.15.
The Zim Laboratories upper circuit limit is ₹120.18 & The Zim Laboratories lower circuit limit is ₹108.74, with a Value of ₹92.34 L. The Delivery Percentage for the day is 0%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Zim Laboratories Fundamentals
P/E Ratio
105.28
P/B Ratio
2.09
Div. Yield
0
Sector P/E
65.01
Sector P/B
3.26
Sec. Div. Yield
0.52
Zim Laboratories Resistance and Support
Pivot 111.98
Resistance
First Resistance
116.96
Second Resistance
119.46
Third Resistance
124.44
Support
First Support
109.48
Second Support
104.5
Third Support
102
Zim Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 06 2026 | 118.85 | 115.15 | 0.61% | 120.18 | 112 |
| Wed Aug 05 2026 | 108.69 | 114.45 | 4.98% | 114.48 | 107 |
| Tue Aug 04 2026 | 109.34 | 109.02 | -1.99% | 110.98 | 106.09 |
Zim Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-19 | Audited Results |
Zim Laboratories News
Zim Laboratories Ltd - 541400 - Earnings Presentation - Q1 FY27
Zim Laboratories Q1 FY27 revenue increased 31.2% YoY to ₹942 Mn, driven by strong export and domestic growth. However, EBITDA declined 40% to ₹34 Mn, and the company reported a net loss of ₹40 Mn due to higher costs.
Aug 06 2026 19:16:17
Zim Laboratories Ltd - 541400 - Board Meeting Outcome for Outcome Of The Board Meeting.
Zim Laboratories' board approved Q1 FY27 consolidated financial results, reporting a net loss of ₹4.02 crore. The standalone net loss for the quarter was ₹3.88 crore, with total income at ₹94.03 crore, after review by Deloitte Haskins & Sells LLP.
Aug 06 2026 13:58:06
Read More
Zim Laboratories Management
| Name | Position |
|---|---|
| Piyush Siddeshwar Nikhade | Company Secretary & Compliance Officer |
| Anwar Siraj Daud | Chairman & Managing Director |
Zim Laboratories Similar Stocks
Zim Laboratories FAQs
The Buying Price of Zim Laboratories share is 115.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zim Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zim Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zim Laboratories shares is 105.28. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zim Laboratories shares is 2.09. Useful to assess the stock's value relative to its book value.
To assess Zim Laboratories’s valuation compare Sector P/E, P/B which are 65.01 & 3.26 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zim Laboratories is 616.62 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zim Laboratories share price is 133.90 & 59.31. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zim Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
